Skip to main content
Equibles

MORGAN STANLEY

Position in LRMR — Larimar Therapeutics, Inc.

CIK 895421 NEW YORK, NY
Back to LRMR Full portfolio

Position in LRMR

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$264,914
-$1,628,743 QoQ
Shares Held
86,858
-79.4% QoQ
Ownership
0.084%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#60
of 163 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 87% Shared 0% None 13%

Common Shares in LRMR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MORGAN STANLEY holds $16,838,649,954 across 523 Biotechnology names. LRMR ranks #309 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RPRX
Royalty Pharma plc
 42,931,597 $2,407,174,637
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,242,139 $1,610,467,694
3 ROIV
Roivant Sciences Ltd.
 42,592,905 $1,507,362,901
4 REGN
Regeneron Pharmaceuticals, Inc.
 1,397,712 $871,529,332
5 MRNA
Moderna, Inc.
 9,538,094 $667,952,718
6 ARGX
Argenx SE
 643,123 $596,670,219
7 TECH
BIO-TECHNE Corp
 6,374,717 $450,373,747
8 INCY
Incyte Corp
 2,948,364 $334,226,536

All Filings in LRMR

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $264,914 86,858
2026-03-31 $1,893,657 420,813
2025-12-31 $518,094 135,983
2025-09-30 $300,396 93,003
2025-06-30 $488,518 169,038
2025-03-31 $884,463 411,380
2024-12-31 $658,590 170,179
2024-09-30 $977,441 149,228
2024-06-30 $388,691 53,613
2024-03-31 $358,921 47,289
2023-12-31 $255,770 56,214
2023-09-30 $96,115 24,334
2023-06-30 $101,366 32,386
2023-03-31 $291,675 64,388
2022-12-31 $2,233,655 540,837
2022-09-30 $1,696,937 530,293
2022-06-30 $1,038,422 529,808
2022-03-31 $2,146,434 529,984
2021-12-31 $127,265 11,795
2021-09-30 $404,240 35,060
2021-06-30 $339,652 34,588
2021-03-31 $381,569 26,117
2020-12-31 $707,707 33,055
2020-09-30 $816,145 53,800
2020-06-30 $458,589 35,688